Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1258893.RAdLR1gJuh7dZN6HK6kj2fBj-3rdtMrM33t3txnDiK1wM130_assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258893.RAdLR1gJuh7dZN6HK6kj2fBj-3rdtMrM33t3txnDiK1wM130_provenance.
• NP1258894.RAVDSSET7Ys3SDvtjxLyIJpuqmRKCzhxIyChLwrw3BTTI130_assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258894.RAVDSSET7Ys3SDvtjxLyIJpuqmRKCzhxIyChLwrw3BTTI130_provenance.
• NP1258900.RAtKCO9GE3aX-cBEumY0_ndXUxzysa1IbO6zq0EFU6n4g130_assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258900.RAtKCO9GE3aX-cBEumY0_ndXUxzysa1IbO6zq0EFU6n4g130_provenance.
• NP1258895.RAL5Ck6ncXO1TDxTeZlARC6_AInu7jRw_IYQd0-BzfM7I130_assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258895.RAL5Ck6ncXO1TDxTeZlARC6_AInu7jRw_IYQd0-BzfM7I130_provenance.
• NP1258896.RALs5Upv8WnIP-Tk6elp-jhN4q7fVo5qXd-sISyrOUsW4130_assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258896.RALs5Upv8WnIP-Tk6elp-jhN4q7fVo5qXd-sISyrOUsW4130_provenance.
• NP1258897.RAKEw4kmVlbIFZQWaXtow3oJoKUsmEMkDj4DByHAiJrhI130_assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258897.RAKEw4kmVlbIFZQWaXtow3oJoKUsmEMkDj4DByHAiJrhI130_provenance.
• NP1258902.RAF_FMytGxrHnLD8g4UBC6A2JMGkspk8_1-ouiv3v57zU130_assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258902.RAF_FMytGxrHnLD8g4UBC6A2JMGkspk8_1-ouiv3v57zU130_provenance.
• NP1258899.RA-iseveHjAsBkih-wdJqcg8CLUaJ2LOMXaSfdnXcb_9M130_assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258899.RA-iseveHjAsBkih-wdJqcg8CLUaJ2LOMXaSfdnXcb_9M130_provenance.
• NP1258901.RAzagYnuyuew4ziIP-U68UwJtrwgY6Qewomf0d87-OTzY130_assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258901.RAzagYnuyuew4ziIP-U68UwJtrwgY6Qewomf0d87-OTzY130_provenance.